SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $27 | -43.8% | 15,146 | 0.0% | 0.00% | – |
Q4 2022 | $48 | -100.0% | 15,146 | -46.4% | 0.00% | -100.0% |
Q2 2022 | $117,000 | -42.9% | 28,246 | -19.9% | 0.00% | 0.0% |
Q1 2022 | $205,000 | -22.3% | 35,246 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $264,000 | -17.0% | 35,246 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $318,000 | -24.6% | 35,246 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $422,000 | +92.7% | 35,246 | +102.0% | 0.00% | +100.0% |
Q1 2021 | $219,000 | -19.5% | 17,446 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $272,000 | +64.8% | 17,446 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $165,000 | -47.1% | 17,446 | -50.0% | 0.00% | 0.0% |
Q2 2020 | $312,000 | -65.6% | 34,892 | -63.3% | 0.00% | -94.4% |
Q1 2019 | $906,000 | -17.0% | 95,000 | 0.0% | 0.02% | -18.2% |
Q4 2018 | $1,091,000 | -88.2% | 95,000 | -82.6% | 0.02% | -80.7% |
Q3 2018 | $9,238,000 | +82.2% | 545,000 | +52.7% | 0.11% | +14.0% |
Q2 2018 | $5,069,000 | – | 357,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |